Cohen & Co Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2019 Annual Meeting of Stockholders held on June 12, 2019. The meeting took place at the Company's New York office. The filing details the voting outcomes for six proposals submitted to security holders, including the election of directors, approval of potential stock issuances related to convertible notes, executive compensation advisory votes, and the ratification of the independent auditor.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data such as revenue, profit, cash flow, margins, debt levels, or liquidity metrics. The filing text does not provide a clear value for these financial indicators.
Material Changes and Voting Results
The following material actions were approved by stockholders:
- Director Election: Five directors were elected: Daniel G. Cohen, G. Steven Dawson, Jack J. DiMaio, Jr., Jack Haraburda, and Diana Louise Liberto. All received significant "For" votes (ranging from 804,753 to 826,721) with minimal "Withheld" votes.
- Convertible Note Approvals: Stockholders approved the potential issuance of Common Stock pursuant to two convertible senior promissory notes:
- The "Cohen IRA Note" (aggregate principal $4,385,628).
- The "EBC Note" (aggregate principal $2,400,000).
- Executive Compensation: Stockholders approved, on an advisory basis, the compensation of named executive officers. They also voted to hold this advisory vote every three years.
- Auditor Ratification: Grant Thornton LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
Voting Participation: A quorum was established with 947,452 shares of Common Stock and 498,355 shares of Series E Preferred Stock present, representing approximately 84.26% of the combined voting power.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risk factors. The primary contingency noted is the potential future issuance of shares if the convertible notes (Cohen IRA Note and EBC Note) are converted, subject to the approvals granted at the meeting.
Key Facts for Investor Verification
- Verify the specific conversion terms and potential dilution impact of the Cohen IRA Note ($4.39M principal) and EBC Note ($2.4M principal) now that stockholder approval has been granted.
- Confirm the composition of the newly elected Board of Directors and their tenure terms.
- Review the Company's proxy statement for detailed breakdowns of executive compensation that were approved on an advisory basis.
- Note that the Series E Preferred Stock votes together with Common Stock but at a ratio of one vote per ten shares.